Printer Friendly
The Free Library
14,758,148 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA approves room-temperature Betaseron. (News).


On January 15, 2002, the Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) approved a form of Betaseron (interferon beta interferon beta Fibroblast interferon IFN-β A 20 kD anti-viral protein with 30% 'homology' with IFN alpha, encoded on chromosome 9, produced by fibroblasts in response to viruses or polyribonucleotides 1 b) that can be kept at room temperature. Avonex and Rebif (both interferon beta-1a) should be refrigerated, but can be stored at 77[degrees] Fahrenheit for up to 30 days. Copaxone (glatiramer acetate) also requires refrigeration refrigeration, process for drawing heat from substances to lower their temperature, often for purposes of preservation. Refrigeration in its modern, portable form also depends on insulating materials that are thin yet effective. , but can be stored at up to 86[degrees] Fahrenheit for one week.

"The new room-temperature formulation provides greater convenience for both people with MS and pharmacies, allowing many more options when traveling and for storage," said Ralph Makar mak·ar  
n. Chiefly Scots
A poet.



[Middle English, variant of maker, maker, poet.]
, Vice President of Marketing at Berlex Laboratories.

Room-temperature Betaseron is available now. For more information, call MS Pathways at: 800-788-1467.
COPYRIGHT 2002 National Multiple Sclerosis Society
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Inside MS
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 22, 2002
Words:112
Previous Article:Cleveland clinic zeroes in on factors that block natural myelin repair. (News).(Brief Article)
Next Article:Society brings MS-related issues to Capitol Hill. (National MS Society News).(multiple sclerosis)(Brief Article)
Topics:



Related Articles
Betaseron near formal approval. (Interferon beta-1b)
About Betaseron .... (Interferon beta-1b for treatment of multiple sclerosis)
Betaseron update. (drug for treatment of multiple sclerosis)
Treatment options - now there are three. (for multiple sclerosis)(includes related information)
Betaseron for secondary-progressive MS?
Rebif trial disappointing for secondary-progressive MS.(multiple sclerosis)
Trial of Betaseron for progressive MS has mixed results.(multiple sclerosis)
New devices may ease use of Copaxone and Betaseron.
FDA approves Rebif. (News).(Brief Article)(Product Announcement)
Rebif [in context].

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles